|
|
Charity match returns bigger and better - Forbes Advocate |
|
Forbes AdvocateSet for Saturday, October 16, Forbes and Calarie will return to the paddock at Spooner Oval for the Forbes v Calarie Dialysis Charity Day rematch. ... |
|
|
Affymax's Hematide Data Fall Short - Toronto Star |
|
Toronto StarThe remaining two trials, EMERALD 1 and EMERALD 2, were conducted in dialysis patients and pitted Hematide's ability against that of Amgen's Epogen to ... |
|
Hospital for gas-hit refuses free dialysis to victim - Times of India |
|
Times of IndiaBHOPAL: Aqueel Ahmed (29), a gas victim and resident of Govindpura, has damaged kidneys and requires dialysis thrice a week. He claimed the Bhopal Memorial ... |
|
Researchers seek new roles for two common materials - PhysOrg.com |
|
PhysOrg.comThe project is an outgrowth to the development by Misiolek and William Van Geertruyden '04 Ph.D., another IMF researcher, of a ceramic dialysis filter whose ... |
|
Affymax Shares Fall on Drug's Heart Safety Concerns - BusinessWeek |
|
BusinessWeekIn the results released today, 22 percent of non-dialysis patients taking Hematide had a cardiovascular complication, compared with 17 percent of those ...Affymax drops as drug trials raise heart concerns ReutersAffymax Shares Plunge On Hematide Study Data Wall Street JournalAffymax and Takeda Announce Phase 3 Trials Meet Primary Endpoints for ... |
|
|
|
|
<< Start < Prev 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 Next > End >>
|
|
Page 1504 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
